Editorial: Steroids and Secosteroids in the Modulation of Inflammation and Immunity is a research paper published in Frontiers in Immunology (2021). On theSindex it has a DataRank of 0.449. It has been cited 19 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.449
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NIAMS NIH HHS
Grant: R01 AR071189
NIAMS NIH HHS
Grant: R01 AR073004
NIAMS NIH HHS
Grant: R21 AR063242
Cancer Research UK
Grant: RCCFEL\100095
Biotechnology and Biological Sciences Research Council
Grant: BB/V006126/1
19-BBSRC-NSF/BIO: Inference of isoform-level regulatory infrastructures with studies in steroid-producing cell
NIAID NIH HHS
Grant: R21 AI149267
BLRD VA
Grant: I01 BX004293
Medical Research Council
Grant: MR/V028995/1
National Institutes of Health
Grant: 5R01AR073004-02
Mechanism of action and function of novel secosteroid 20(OH)D3 in the skin
National Institutes of Health
Grant: 5R21AI149267-02
Canonical and non-canonical vitamin D activation pathways in systemic lupus
National Institutes of Health
Grant: 1I01BX004293-01A1
CYP11A1-derived secosteroids as therapeutic agents in UVB induced skin cancer
National Institutes of Health
Grant: 5R01AR064825-04
20(OH) Vit D3, T Cells, and Arthritis
National Institutes of Health
Grant: 5R01AR071189-02
Significance of metabolic activation of lumisterol in the skin
National Institutes of Health
Grant: 5R01AR069010-02
Inhibitory Receptors and Autoimmune Arthritis
National Institutes of Health
Grant: 5R21AR063242-02
Discovery of tissue-selective, nonhypercalcemic VDR modulators for RA treatment
Fields of Study
MeSH Terms
Keywords